Showing results (301-310 of 332) with videos related to

Sort By:
Pageof 34
Therapeutic Advances in Neurological Disorders|May 26, 2021
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trialAlasdair J Coles, Douglas L Arnold, Ann D Bass, et al.
Multiple Sclerosis and Related Disorders|January 21, 2021
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 yearsAnn D Bass, Rafael Arroyo, Aaron L Boster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2019
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studiesGiancarlo Comi, Raed Alroughani, Aaron L Boster, et al.
Journal of Animal Science|March 10, 2023
Evaluation of growth, meat quality, and sensory characteristics of wool, hair, and composite lambsMikayla L Heimbuch, Jessie B Van Buren, Brooklyn S Epperson, et al.
EMBO Reports|May 26, 2018
The β3-integrin endothelial adhesome regulates microtubule-dependent cell migrationSamuel J Atkinson, Aleksander M Gontarczyk, Abdullah Aa Alghamdi, et al.
The International Journal of Cardiovascular Imaging|May 31, 2024
Human vs. machine vs. core lab for the assessment of coronary atherosclerosis with lumen and vessel contour segmentation with intravascular ultrasoundRonald D Bass, Hector M Garcia-Garcia, Jorge Sanz-Sánchez, et al.
Frontiers in Neurology|April 11, 2019
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical SettingsKrista Barclay, Robert Carruthers, Anthony Traboulsee, et al.
Physical Review Letters|July 2, 2016
Precision Measurement of the Radiative β Decay of the Free NeutronM J Bales, R Alarcon, C D Bass, et al.
ATS Scholar|April 19, 2021
ATS Core Curriculum 2020. Adult Critical Care MedicineBaşak Çoruh, Susan Pasnick, Megan Acho, et al.
Pageof 34